 |
Top 18 medical and healthcare startups in Vancouver
Last updated: April 17, 2024 |
1
Funding: $887M
AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.
AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.
2
Funding: $237.9M
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
3
Funding: $148.3M
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
4
Funding: $141.4M
Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.
Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.
5
Funding: CN¥250M
Gandeeva Therapeutics is a precision biotechnology company harnessing the power of cryogenic electron microscopy and machine learning.
Gandeeva Therapeutics is a precision biotechnology company harnessing the power of cryogenic electron microscopy and machine learning.
6
Funding: $27.6M
Aspect Biosystems is an award-winning biotechnology company specializing in 3D bioprinting and tissue engineering. We bring together a multi-talented team of individuals to develop cutting-edge custom human tissue technology for use in the life sciences.
Aspect Biosystems is an award-winning biotechnology company specializing in 3D bioprinting and tissue engineering. We bring together a multi-talented team of individuals to develop cutting-edge custom human tissue technology for use in the life sciences.
7
Funding: $5.5M
Sitka Biopharma is a preclinical biotechnology company focused on developing its breakthrough nanoparticle platform technology to increase absorption of drugs in difficult-to-penetrate tissues.
Sitka Biopharma is a preclinical biotechnology company focused on developing its breakthrough nanoparticle platform technology to increase absorption of drugs in difficult-to-penetrate tissues.
8
Funding: $4M
GeniusHealth was born with the mission of helping every behavioral and neuro-disorder genius to achieve their life goals. We are committed to challenging the status quo of medicine and care delivery to help people living with ADHD, ASD, and other cognitive impairments. We are passionate about bringing together top scientists and clinical know-how with great multi-culture experience to forever change how medicine is designed and delivered.
GeniusHealth was born with the mission of helping every behavioral and neuro-disorder genius to achieve their life goals. We are committed to challenging the status quo of medicine and care delivery to help people living with ADHD, ASD, and other cognitive impairments. We are passionate about bringing together top scientists and clinical know-how with great multi-culture experience to forever change how medicine is designed and delivered.
9
Funding: CA$2.1M
eTreatMD develops application that provides users with an alternative to traditional healthcare solutions when treating their chronic acne. The app analyzes the skin and provides product recommendations based on user preferences.
eTreatMD develops application that provides users with an alternative to traditional healthcare solutions when treating their chronic acne. The app analyzes the skin and provides product recommendations based on user preferences.
10
Funding: $1M
Bio Conscious Technologies uses machine learning to better understand human metabolism. By integrating medical and wearable sensor data we identify risk factors, monitor disease progression and predict complications associated with major chronic conditions before they occur.
Bio Conscious Technologies uses machine learning to better understand human metabolism. By integrating medical and wearable sensor data we identify risk factors, monitor disease progression and predict complications associated with major chronic conditions before they occur.
11
Funding: $1,667M
Interactive Health International develops interactive medical education platform - CyberPatient for health professionals.
Interactive Health International develops interactive medical education platform - CyberPatient for health professionals.
12
Funding: $963.5K
Microbiome Insights is a global leader providing end-to-end services for microbiome DNA sequencing and state-of-the-art bioinformatics.
Microbiome Insights is a global leader providing end-to-end services for microbiome DNA sequencing and state-of-the-art bioinformatics.
13
Funding: $250K
ABOzymes Biomedical is overcoming the blood group barriers for blood transfusions and organ transplants.
ABOzymes Biomedical is overcoming the blood group barriers for blood transfusions and organ transplants.
14
Funding: $230K
Scanbo is a revolutionary, a non-invasive portable handheld device designed to perform rapid health assessment of an individual by recording key vitals: Body Temperature, Blood Oxygen Saturation, Heart Rate, ECG, Blood Pressure, Blood Glucose.
Scanbo is a revolutionary, a non-invasive portable handheld device designed to perform rapid health assessment of an individual by recording key vitals: Body Temperature, Blood Oxygen Saturation, Heart Rate, ECG, Blood Pressure, Blood Glucose.
15
Recon Health enables real time continuous health monitoring for individuals managing chronic diseases at home.
16
AI Talos provides AI-guided decision-making support for breast cancer screening (Thermography), enabling you to decisively confirm what you suspect, detect what you potentially missed and concentrate on questionable studies that need more attention.
18
Genevant brings world-class delivery platforms that include best-in-class lipid nanoparticle (LNP) technology and next generation ligand conjugate technology, the industry’s most robust and expansive LNP patent estate, decades of experience and expertise in nucleic acid drug development headed by the team that enabled delivery for the world’s only approved small interfering RNA (siRNA)-LNP product, and an innovative culture that positions us to maintain our leadership for years to come.